ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China flag China · Delayed Price · Currency is CNY
12.49
+0.09 (0.73%)
Nov 17, 2026, 3:04 PM CST

ChenGuang Biotech Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,0336,0495,8035,6715,0743,950
Other Revenue
509.6509.61,1911,2001,222923.77
6,5436,5596,9946,8726,2964,874
Revenue Growth
-4.01%-6.22%1.79%9.14%29.18%24.55%
Cost of Revenue
5,7855,7356,5356,0725,4524,175
Gross Profit
758.21824.38459.36799.37843.87698.53
Selling, General & Admin
208.28228.04208.33213.08249.21210.35
Research & Development
125.85166.24128.697.4129.0394.79
Other Operating Expenses
29.5712.91-1.787.0916.8213.66
Operating Expenses
370.11412.09335.27318.45395.16319.48
Operating Income
388.1412.29124.1480.92448.71379.05
Interest Expense
-103.97-90.83-114.42-83.51-67.21-53.15
Interest & Investment Income
55.8284.8158.36104.2863.2739.58
Currency Exchange Gain (Loss)
-0.66-0.665.542.4121.37-5.63
Other Non Operating Income (Expenses)
-21.37-3.41-34.033.31-2.367.61
EBT Excluding Unusual Items
317.92402.239.55507.43463.78367.46
Gain (Loss) on Sale of Investments
2.449.27-5.115.36-5.020.56
Gain (Loss) on Sale of Assets
-2.111.464.89-0.631.080.1
Asset Writedown
9.06-6.94-0.46-1.1-1.32-10.91
Other Unusual Items
65.131.8868.0844.7643.2440.85
Pretax Income
392.41437.87106.95555.82501.76398.07
Income Tax Expense
50.6762.9928.9961.6565.6747.47
Earnings From Continuing Operations
341.74374.8877.96494.17436.09350.6
Minority Interest in Earnings
-6.34-616.09-14.45-2.050.92
Net Income
335.4368.8794.05479.72434.03351.51
Net Income to Common
335.4368.8794.05479.72434.03351.51
Net Income Growth
0.04%292.21%-80.40%10.53%23.47%31.29%
Shares Outstanding (Basic)
483483517532533529
Shares Outstanding (Diluted)
483483517532533529
Shares Change
-0.88%-6.62%-2.76%-0.14%0.80%4.13%
EPS (Basic)
0.690.760.180.900.810.67
EPS (Diluted)
0.690.760.180.900.810.67
EPS Growth
0.92%320.02%-79.84%10.68%22.49%26.09%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
76.877.65-372.35-777.67558.78-216.92
Free Cash Flow Per Share
0.160.16-0.72-1.461.05-0.41
Dividend Per Share
0.3000.3000.1300.1300.1600.130
Dividend Growth
130.77%130.77%0%-18.75%23.08%30.00%
Gross Margin
11.59%12.57%6.57%11.63%13.40%14.33%
Operating Margin
5.93%6.29%1.77%7.00%7.13%7.78%
Profit Margin
5.13%5.62%1.34%6.98%6.89%7.21%
Free Cash Flow Margin
1.17%1.18%-5.32%-11.32%8.88%-4.45%
EBITDA
582.54594.82290.76633.47593.27509.67
EBITDA Margin
8.90%9.07%4.16%9.22%9.42%10.46%
D&A For EBITDA
194.43182.53166.67152.54144.56130.62
EBIT
388.1412.29124.1480.92448.71379.05
EBIT Margin
5.93%6.29%1.77%7.00%7.13%7.78%
Effective Tax Rate
12.91%14.39%27.11%11.09%13.09%11.92%
Revenue as Reported
6,5436,5596,9946,8726,2964,874